TGINSIGHT SIMILAR POSTS
Source channel @githubtrending · Post #15321 · Dec 9
#go#game_engine#game_engine_2d#game_engine_3d#game_engine_development#game_engine_framework#gameengine#go#golang Kaiju Engine is a fast, modern 2D/3D game engine written in Go and powered by Vulkan, designed for simplicity and high performance. It runs on Windows, Linux, Android, and is working on Mac support. Kaiju offers much faster rendering speeds and lower memory use than popular engines like Unity, making game development quicker and more efficient. It uses Go’s garbage collector to help prevent common programming errors, improving stability. You can write games directly in Go, and the engine supports local AI integration and a flexible UI system using HTML/CSS. Although the editor is still in development, the engine itself is production-ready, offering a powerful tool for developers who want speed and simplicity. https://github.com/KaijuEngine/kaiju
Search: #clinicalstage
@venturevillagewall · Post #3534 · 12/20/2024, 09:31 AM
$2.16M Fundraising by Umecrine Umecrine Cognition, a Swedish clinical-stage pharmaceutical firm, has raised $2.16 million to advance its innovative drug development targeting neurological disorders. The funding round took place on December 19, 2024. #UmecrineCognition#Pharmaceuticals#NeurologicalDisorders#Funding#Healthcare#ClinicalStage#Sweden
@venturevillagewall · Post #3642 · 12/21/2024, 10:23 AM
PeproMene Bio Secures $11M Round PeproMene Bio, Inc., a clinical-stage biotech firm based in Irvine, CA, has successfully raised $11 million in funding. The investment round closed on December 18, 2024, focusing on innovative therapies targeting cancers and immune disorders. More info: PeproMene Bio #Biotech#Funding#Cancer#ImmuneDisorders#California#ClinicalStage#Therapies#Investment#Healthcare#Innovation#PeproMeneBio#Pharmaceuticals#MedicalResearch#DrugDevelopment
@venturevillagewall · Post #3412 · 12/18/2024, 12:11 PM
$60M Funding for Psioxus Psioxus Therapeutics has successfully secured $60M in funding as part of its latest round, scheduled for December 17, 2024. This funding aims to advance its innovative tumor gene therapy platform focused on improving cancer treatment outcomes. #Funding#Cancer#Biotech#Oncology#GeneTherapy#Therapeutics#ClinicalStage#Investment#Healthcare#Psioxus#AkamisBio#Tumor#LifeScience#MedicalResearch#Therapy#Innovative#Impact#Technology#Platform